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SUMMARY 
Neural development requires crosstalk between signaling pathways and chromatin. 
In this study, we demonstrate that neurogenesis is promoted by an interplay between 
the TGFβ pathway and the H3K27me3 histone demethylase (HDM) JMJD3. 
Genome-wide analysis showed that JMJD3 is targeted to gene promoters by Smad3 in 
neural stem cells (NSCs) and is essential to activate TGFβ-responsive genes. In vivo 
experiments in chick spinal cord revealed that the generation of neurons promoted by 
Smad3 is dependent on JMJD3 HDM activity. Overall, these findings indicate that 
JMJD3 function is required for the TGFβ developmental program to proceed. 
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INTRODUCTION 
Epigenetic mechanisms that regulate access to the genetic material govern cell 
differentiation and embryonic development. This epigenetic control is mainly mediated 
by covalent modifications of histones and DNA (Kouzarides, 2007). Recently, histone 
methylation has received special attention as an essential regulator of gene expression. In 
particular, methylation of lysine 27 of histone H3 (H3K27me3) has been found to be an 
important regulator of embryonic development and cell homeostasis (Margueron and 
Reinberg, 2010; Morey and Helin, 2010). The enzymes responsible for this activity are 
Enhancer of Zeste Homologs 1 and 2 (EZH1/2) (Cao et al., 2002; Czermin et al., 2002; 
Kuzmichev et al., 2002). H3K27me3 is recognised by the chromodomain of the 
polycomb protein that forms part of PRC1 (Cao et al., 2002; Lois et al., 2010). The 
recruitment of PRC1 leads to final transcriptional repression (Cao et al., 2002), a state 
which can be reversed by the removal of H3K27me3 marks by Jumonji C (JmjC) 
domain-containing proteins, JMJD3 and UTX histone demethylases (Agger et al., 2007; 
De Santa et al., 2007; Lan et al., 2007; Lee et al., 2007). The importance of the balance 
between methyltransferase and demethylase activity is reflected by the fact that many key 
developmental promoters are often marked by H3K27me3 (Boyer et al., 2006; Bracken et 
al., 2006; Lee et al., 2006; Pan et al., 2007). Indeed both UTX and JMJD3 derepress HOX 
genes and a subset of neural and epidermal differentiation genes (Agger et al., 2007; 
Burgold et al., 2008; Jepsen et al., 2007; Lan et al., 2007; Lee et al., 2007; Sen et al., 
2008). In particular, UTX is enriched around the transcription start sites of many HOX 
genes in primary human fibroblasts, which correlates with a strong decrease in 
H3K27me3 levels. However in embryonic stem cells (ESCs), in which these genes are 
repressed, UTX is excluded from the HOX loci (Agger et al., 2007; Lan et al., 2007).  In 
addition, inhibition of a zebrafish UTX homologue or the Caenorhabditis elegans JMJD3 
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orthologue leads to mis-regulation of HOX genes and developmental defects (Agger et 
al., 2007; Lan et al., 2007). On the other hand, in isolated cortical progenitor cells, SMRT 
prevents retinoic-neuronal differentiation by repressing the expression of JMJD3, which 
can activate specific components of the neurogenic program (Jepsen et al., 2007). These 
findings show an important contribution of JMJD3/UTX during development. However, 
in spite of the essential role of H3K27me3 and its demethylases during development, we 
do not know how they respond to developmental signals.  
 Signaling pathways are essential during development. Specifically, transforming 
growth factor β (TGFβ) signaling is important for both embryonic development and 
tissue homeostasis (Moustakas and Heldin, 2009). At the cellular level, TGFβ regulates 
cell growth, differentiation, adhesion, migration and death in a cell context-dependent 
manner (Yang and Moses, 2008). On the other hand, alterations in TGFβ signaling lead 
to congenital malformations, inflammation, and cancer [reviewed by (Gordon and Blobe, 
2008; Massague et al., 2005)]. Mechanistically, TGFβ transduces signals from the plasma 
membrane by interacting with type I and type II receptors, which are serine/threonine 
kinases. Cytokine binding induces phosphorylation and activation of Smad2 and Smad3 
at C-terminal serine residues, while activated Smad2/3 proteins interact with Smad4 to 
enter the nucleus and regulate gene expression (Feng and Derynck, 2005; Shi and 
Massague, 2003; Varga and Wrana, 2005). The biological output of TGFβ pathway 
activation depends on the subset of genes that are regulated in each cellular context 
(Massague, 2000), which, in turn, varies with each particular combination of cofactors. 
Specific chromatin modifier enzymes have been associated with activated Smad proteins, 
such as histone acetyltransferases P/CAF, CBP/p300 or the ATP-dependent remodeling 
factor Brg1 (Feng and Derynck, 2005; Massague et al., 2005; Xi et al., 2008). In 
particular, the TGFβ effectors Smad2/3 interact with JMJD3 to de-repress certain loci in 
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ESCs (Dahle et al., 2010; Kim et al., 2011). Here, we demonstrate by genome-wide 
analysis and in vivo experiments that TGFβ-neural development-associated function 
requires JMJD3 activity. 
The results of the present study show by ChIP-Seq analysis that JMJD3 and 
Smad3 co-localize at the transcriptional start site (TSS) of TGFβ responsive genes in 
neural stem cells (NSCs). Moreover, genome wide expression profiling revealed that the 
neural developmental targets of TGFβ signaling require JMJD3 for proper regulation. 
Finally, in vivo experiments in chick developing spinal cord demonstrated that JMJD3 
activity is essential for Smad3-induced neuronal differentiation. 
MATERIALS AND METHODS 
Cell culture and CoIP assays 
Human 293t cells were grown under standard conditions (Blanco-Garcia et al., 2009). 
Mouse NSCs, provided by Dr K. Helin, were dissected out from cerebral cortex of mouse 
embryos (E12.5) and cultured in a poly-D-lysine (5µg/ml, 2h 37°C) and laminine (5 
µg/ml 37°C, 4 h 37ºC) precoated dishes growing with a media composed by equal parts 
of DMEM F12 (without Phenol Red, Gibco) and Neural Basal Media (Gibco) containing 
Penicillin/Streptomycin and Glutamax (1%), N2 and B27 supplements (Gibco), non 
essential aminoacids (0.1mM), sodium pyruvat (1mM), Hepes (5 mM), Heparin (2 mg/l), 
bovine serum albumin (25 mg/l) and β mercaptoethanol (0.01 mM). We add fresh 
recombinant human EGF (R&D systems) and FGF (Invitrogen) to 20 ng/ml and 10 ng/ml 
final concentrations respectively. NSCs preserve the ability to self-renew and to generate 
a wide range of differentiated neural cell types (Calloni et al., 2009; Gossrau et al., 2007; 
Sasaki et al., 2006). TGFβ (Millipore) was used at a final concentration of 5 ng/ml. CoIP 
experiments were carried out as described (Akizu et al., 2010).  
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Plasmids and recombinant proteins  
Flag-Smad2, Flag-Smad3 and Flag-Smad3S/D cloned into pCIG vector were kindly 
provided by Dr E. Martí (Garcia-Campmany and Marti, 2007). pCIG-Myc-JMJD3 and 
pCIG-Myc-JMJD3 DN has been previously described (Akizu et al., 2010). shRNA 
against chicken JMJD3 was cloned in pShin vector (Kojima et al., 2004). shRNA against 
mouse JMJD3 is cloned into pLKO.1-puro vector and it was purchased from Sigma 
[shJMJD3(2837), TRCN0000095265]. GST-Smad3 full-length and GST-Smad3 MH1 
domain (1-155) were kindly provided by Dr J. Massagué (Xu et al., 2003). GST-Smad3 
MH2 (199-425) and Linker-MH2 (146-425) domains were acquired from Addgene. 
Antibodies and reagents 
TGFβ was acquired from Millipore (GF111). Antibodies used were anti: mouse Smad3 
(Abcam 55480), rabbit ChIP Grade Smad3 (Abcam 28379), rabbit PhosphoSmad3 (Cell 
Signaling, mAb9520), mouse Flag (Sigma M2), mouse Nestin (BD Bioscience, 611653), 
mouse b-Tubulin III (Tuj1, Covance MMS-435P), rabbit trimethyl H3K27 (Millipore, 
07449), rabbit Sox2 (Invitrogen 48-1400), mouse HuC/D (MP, A21271), rabbit Gfap 
(Dako, z0334), rabbit Id1 (Santa Cruz, sc488), rabbit ph3 (Upstate 06-570) and mouse 
Mnr2 (DSHB, 81.5C10). Anti rabbit JMJD3 was kindly given by Dr K. Helin (Agger et 
al., 2009).  Anti mouse Myc antibody was a gift from Dr S. Pons. Anti guinea Pig Lbx1 
was kindly provided by Dr E. Martí.  
 Microarrays analysis 
RNA-s from 106 non stimulated or TGFβ-stimulated for 2.5 h KD C and KD JMJD3 cells 
were supplied to the Microarrays Unit of the Centre for Genomic Regulation (CRG) for 
quality control, quantification, reverse transcription, labeling and hybridization using an 
Agilent Platform with Whole Mouse Genome microarrays. Triplicates were analyzed for 
untreated and TGFβ-treated KD C and KD JMJD3 samples. Fold Changes (FCs) between 
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untreated and the corresponding TGFβ treated samples were calculated applying the 
AFM tool. The list of JMJD3 dependent TGFβ responsive genes was generated using a 
two-step protocol. First, we identified the genes putatively sensitive to TGFβ regulation. 
These were defined as those genes from the KD C with significant values (adjusted p-
value ≤0.05) for the fold change between gene expression levels in TGFβ treated and 
untreated cells (this fold change is abbreviated as FC). Second, we used the resulting 
2744 gene set to generate the list of candidate genes. This was done by generating two 
subsets of genes: the subset of genes for which FC remains significant in the KD JMJD3 
array (adjusted p-value ≤0.05) but showed a lower FC (differences larger than 25% of the 
corresponding FC in the KD C array); and the subset of genes with non-significant FC (p-
value ≥ 0.1) in the KD JMJD3 array experiment. We subsequently put these two subsets 
together to produce a final list of 781 candidates. Microarray data have been deposited in 
GEO database under accession No. GSE35361. 
ChIP assays  
ChIPs from NSCs were carried out using previously described procedures (Frank et al., 
2001) with modifications: 3x106 NSCs untreated or treated with TGFβ (5 ng/ml, for the 
indicated times) were fixed with di (N-succinimidyl) glutarate (DSG) 0.2 mM, 45 min at 
room temperature followed of FA 1% 20 min. Fixation was stopped by addition of 0.125 
mM glycine. The sonication step was performed in a Bioruptor sonicator (12 min, 30 sec 
ON, 30 sec OFF). ChIP DNA was analyzed by qPCR in a LightCycler 480 PCR system 
(Roche). ChIPs from electroporated chick cells were essentially performed as described 
previously (Akizu et al., 2010).  
ChIP-Seq procedure  
A standard ChIP protocol was used. Before sequencing, ChIP DNA was prepared by 
simultaneously blunting, repairing and phosphorylating ends according to 
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manufacturer’s instruction (Illumina). The DNA was adenylated at 3' end and recovered 
by Qiaquick PCR purification kit (Qiagen) according to the manufacturer’s 
recommendations. Adaptors were added by ligation and the ligated fragments were 
amplified by PCR, resolved in a gel and purified by Qiagen columns. Samples were 
loaded into individual lanes of flow cell. We generated almost 20 million 36 bp reads 
for each ChIP sample. Reads were mapped with bowtie (Langmead et al., 2009) to the 
UCSC (Fujita et al., 2011) Mus musculus genome release 9; only sequence reads 
mapping at unique locations were kept. Peaks were called with MACS (Zhang et al., 
2008) on each sample with Input as control. Only one read from each set of duplicates 
was kept, p-value cutoff for peak detection was set to 1e-4 and PeakSplitter was 
invoked. The total number of peaks called for Smad3 and for JMJD3 were 98086 and 
63154, respectively. PeakAnalyzer (Salmon-Divon et al., 2010) was used to find the 
closest upstream or downstream refGene Transcription Start Site (TSS). R language and 
Bioconductor (Gentleman et al., 2004), including packages ShortRead and IRanges 
(Morgan et al., 2009), were used for further annotation and statistical analysis. ChIP-
Seq data have been deposited in GEO database under accession No. GSE36673. 
Size exclusion Chromatography 
Size exclusion chromatography was performed with whole cell extracts in a Superose-6 
10/300 gel filtration column (GE Healthcare) on AKTA purifier system (GE 
Healthcare).  
Purification of recombinant proteins and GST pull down assays 
GST pull-downs were performed essentially as described previously (Valls et al., 2003).  
Immunoblotting 
Immunoblotting was performed with standard procedures and visualized by means of an 
ECL kit (Amersham).  
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mRNA extraction and qPCR  
mRNA from NSCs was extracted with QIAGEN columns following manufacturer’s 
instructions. mRNA from dissected neural tubes was extracted by TRIZOL (Invitrogen) 
protocol. qPCR was performed with Sybergreen (Roche) in LC480 Lightcycler (Roche) 
using the primers in Table S2.  
Indirect immunofluorescence 
The collected embryos’ brachial regions were fixed for 2 h at 4ºC in 4% 
paraformaldehyde. Indirect immunofluorescence was essentially performed as described 
previously (Akizu et al., 2010). 
In situ hybridization  
Whole-mount embryos’ RNA in situ hybridization was done following standard 
procedures (Schaeren-Wiemers and Gerfin-Moser, 1993) using ESTbank probes for 
chick JMJD3, NeuroD1, Ngn2 and Smad3.  
GFP+ cell position measurement  
Images from electroporated (EP) neural tubes were obtained on Leica SP5 confocal. 
Maximum projection of 10 sections was generated and used for quantification. Image J 
software was used to quantify the position of GFP+ cells along the mediolateral axis. Y 
coordinate was used to define the GFP+ cell position respect to the lumen (Y=0). First, 
neural tube mediolateral axis was divided in 4 equal quadrants encompassing the entire Y 
axis (from lumen to mantle zone). Second, the Y value of each GFP+ cell was defined. 
Third, GFP+ cells were grouped in one of the quadrants according to their Y values. 
Finally, the percentage of GFP+ cells in each quadrant was calculated and the average 
from all quantified sections was represented in the graph (Figure 5D). 
Lentiviral transduction 
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Lentiviral production was performed as described (Rubinson et al., 2003). Viral particles 
were added to NSCs and  infected cells were selected with puromycine (1µg/ml) 24 h 
later.  
Chick in ovo electroporation 
In ovo electroporation experiments were performed as previously described (Akizu et al., 
2010). Total EP DNA was adjusted to 3.5 µg/µl. 
Statistical analysis 
Quantitative data were expressed as mean and standard deviation (s.d.) of at least three 
biologically independent experiments. The significance of differences between groups 
was assessed using the Student's t-test (*p<0.05; **p<0.01). 
RESULTS   
Phosphorylated Smad3 interacts with JMJD3 in NSCs  
 The TGFβ signaling pathway has recently been reported to have a role in neural 
development (Garcia-Campmany and Marti, 2007). On the other hand, JMJD3 regulates 
many developmental and, in particular, key neural promoters (Jepsen et al., 2007). Given 
this, we wondered whether JMJD3 cooperated in TGFβ-dependent neural development. 
In order to address this question, we used a suitable neural cell model: NSCs. First, we 
demonstrated that JMJD3 and the phosphorylated form of Smad3 (Smad3P) co-purified 
in TGFβ-treated NSC extracts in a gel filtration assay (Figure 1A). We then confirmed 
that JMJD3 interacts with the Smad3P by co-immunoprecipitation (Co-IP) experiments 
(Figure 1B). Next, by pull-down assay, we identified that the Smad3 regions responsible 
for the interaction with JMJD3 are the MH1 and linker domains (Figure 1C, lanes 3 and 
5). As these are the least-well conserved domains between Smad2 and Smad3 proteins 
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(Figure S1A), we tested the specificity of the JMJD3 interaction with Smad proteins. Co-
IP assays showed that Smad2 did not interact with JMJD3 (Figure S1B and S1C).  
 We then wanted to assess whether the Smad3-JMJD3 interaction was biologically 
relevant for TGFβ function in NSCs. To this end, we established a JMJD3 knockdown 
(KD) cell line of NSCs that expresses low levels of JMJD3 without affecting Smad3 
expression (Figure 1D) and maintaining neural stem cell identity (Figure S2). Then, we 
analyzed the effects of JMJD3 depletion on the TGFβ response. As shown in Figure 1E, 
TGFβ treatment of control cells led to a clear decrease in Nestin, a neural progenitor 
marker. In contrast, TGFβ failed to down-regulate Nestin in JMJD3 KD cells. These 
findings suggest that changes in neural stem cell identity mediated by TGFβ depend on 
JMJD3.  
 
TGFβ-induced gene expression profile depends on JMJD3  
 To explore whether JMJD3 contributes to the TGFβ response, we set out to 
identify genes co-regulated by TGFβ and JMJD3. For this, we performed a microarray 
expression experiment with control (C KD) and JMJD3-depleted NSCs (JMJD3 KD) 
left untreated or treated with TGFβ for 2.5 h (Figure 2A). We confirmed the results of 
the two microarrays by qPCR of 12 genes selected to cover the whole range of changes 
in gene expression (Figure S3A). Interestingly, from 2744 TGFβ-responsive genes in 
control cells (p-value ≤ 0.05: 1493 genes up- and 1251 genes down-regulated, see 
Figure 2B), 781 targets were not affected to the same extent by TGFβ in JMJD3 
depleted cells (see Methods, Figure 2B and Table S1). These correspond to genes 
regulated by TGFβ in control cells but not efficiently regulated in JMJD3-depleted cells 
after TGFβ treatment.  Of these 781 candidates, 381 showed JMJD3 dependency for 
transcription activation (Figure 2B, left panel). This was more evident for genes with 
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larger transcriptional changes upon TGFβ treatment (75% of genes with FC ≥2 were not 
activated in KD JMJD3 cells, Figure S3B), in agreement with an activating role for 
JMJD3.  Nevertheless, JMJD3 seems to be required to direct or indirectly repress 400 
TGFβ down regulated target genes (Figure 2B, right panel). To further characterize the 
differences between C KD and JMJD3 KD cells in response to TGFβ signaling, we 
performed an enrichment analysis of Gene Ontology (GO) terms over the 781 JMJD3-
dependent genes (Table S1) to identify those biological processes most sensitive to 
JMJD3 levels in response to TGFβ signaling. The results of this analysis showed that 
the most significantly enriched GO terms were associated with development 
("anatomical structure development", "organ development" and "developmental 
process" with adjusted p-values of 1.76e-11, 2.75e-11 and 3.86e-11, respectively) 
(Figure 2C). In addition, other well known TGFβ functions such as apoptosis, or cell 
proliferation and differentiation were also dependent of JMJD3  (Figure 2C). Overall, 
this result points to a key role for JMJD3 in the regulation of TGFβ-responsive genes, in 
particular genes associated to developmental processes. Interestingly, some class II 
basic helix-loop-helix (bHLH) proneural genes such as neurogenin 2 (Ngn2) and 
inhibitor of DNA binding 3 (Id3) (Figure 2C and Table S1), whose activity is essential 
during neurogenesis, were not fully induced by TGFβ in KD JMJD3 cells.  
 
Smad3 and JMJD3 co-localize on gene promoters 
 The ability of the TGFβ signaling pathway and JMJD3 to co-regulate gene 
transcription suggests that Smad3 and JMJD3 bind a subset of common target genes. To 
investigate this hypothesis, we identified the genome-wide binding sites of Smad3 and 
JMJD3 in NSCs treated with TGFβ by sequencing DNA fragments of 
immunoprecipitated chromatin (ChIP-Seq) (Figure 3A). With values normalized to the 
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input, 98086 and 63154 peaks were detected in ChIP data for Smad3 and JMJD3, 
respectively. To validate the ChIP-Seq results as well as the specificity of JMJD3 and 
Smad3 antibodies we performed ChIP followed by qPCR for a representative set of 
Smad3 and JMJD3 target genes. Specifically, we selected Smad3 and JMJD3 promoter 
targets corresponding to genes regulated at transcriptional level by Smad3 and JMJD3 
(seven up-regulated and seven down-regulated, see Figure S4A and S4B), four promoters 
of genes not regulated in the microarray experiment (Figure S4A and S4B) and finally, to 
test the specificity of the antibodies we chose three areas corresponding to intergenic 
regions occupied only for Smad3 (named as IGR1, IGR2 and IGR3) and three only by 
JMJD3 (named as IGR4, IGR5 and IGR6) (Figure S4A and S4B). Then, we examined the 
genomic distribution of the Smad3 and JMJD3 peaks. Our results showed that both 
Smad3 and JMJD3 peaks are distributed across various genomic regions (Figure S4C), 
consistent with what has been found in other cell contexts (De Santa et al., 2009; Kim et 
al., 2011). Importantly, the overlapping regions between Smad3 and JMJD3 are mainly 
located around the transcription start site (TSS) (Figure S4D and S4E), containing a 
common peak maximum around -100 bp from the TSS (Figure 3B and 3D). As shown in 
Figure 3C, 6158 promoters (-1000 to 0 pb from the TSS) were found to be targeted by 
both Smad3 and JMJD3. 
  Interestingly, of the 381 genes that showed a JMJD3-dependency for 
transcriptional activation in the microarray experiment, 215 (56.4%) were bound by 
Smad3 and JMJD3 (Figure 3E, left panel and Table S1). On the other hand, 192 genes 
out of those 400  (48%) down regulated in the microarray experiment were also direct 
targets of Smad3 and JMJD3 (Figure 3E, right panel)  suggesting a potential role of 
JMJD3 in transcriptional repression. Enrichment analysis of GO terms over these 407 
(215 up- plus 192 down-regulated) Smad3 and JMJD3 co-regulated direct targets 
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showed that the most enriched GO terms are again associated with several different 
aspects of development  (Figure 3F).  
 Taken together, these results indicate that JMJD3 cooperates with Smad3 
regulating the expression of genes involved in development. 
 
JMJD3 permanency at promoters is independent on Smad3 
 To further analyze the mechanism by which TGFβ and JMJD3 cooperate to 
activate transcription, we studied several genes involved in development and neural 
function (Slc16a6, Eomes, Ngn2, Ctgf, and Stx3) from those listed in Table S1. First, we 
performed a time-course experiment of Smad3 and JMJD3 recruitment at the promoters 
under study. Results illustrated in Figure 4A and 4B show that soon after activation (30 
min), Smad3 and JMJD3 were recruited to the TGFβ-responsive promoters but not to the 
control gene Hbb. Three hours later Smad3 had been displaced, but JMJD3 remained at 
most promoters (Slc16a6, Eomes, Ngn2 and Ctgf) correlating with mRNA accumulation 
(Figure 4A-B and 4D). Given the known HDM activity of JMJD3, we wondered whether 
its recruitment resulted in H3K27me3 removal. It was observed that H3K27me3 levels  
decreased from 3 h after TGFβ treatment in the four methylated promoters (Figure 4C). 
This change was probably due to JMJD3 because no changes were detected in 
H3K27me3 levels in JMJD3 KD cells (Figure S5). However, this decrease was slight and 
not always correlated with mRNA accumulation (Figure 4D). These data suggest that in 
addition to H3K27me3 activity other JMJD3-dependent functions might be involved in 
TGFβ-responsive promoter activation.   
 The simultaneous binding of Smad3 and JMJD3 to common targets 30 min after 
TGFβ treatment led us to investigate whether Smad3 reduction affects JMJD3 
recruitment to promoters. To address this question, we first established a Smad3-depleted 
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NSC line (Smad3 KD) which express low levels of Smad3 protein without affecting 
JMJD3 expression (Figure 4E and Figure S2C). Then, we analyzed the binding of Smad3 
and JMJD3 in each of the three cell lines (Figure 4F and 4G). We observed that Smad3 
binding to the promoters increases upon TGFβ treatment in both the C KD and JMJD3 
KD cell lines, while, as expected, the binding was severely reduced in the Smad3 KD cell 
line (Figure 4F). On the other hand, JMJD3 recruitment to promoters upon TGFβ 
treatment was only detected in the C KD cell line (Figure 4G). 
 Taken together, these findings indicate that the TGFβ pathway activates the 
expression of some target genes through a rapid recruitment of JMJD3 by Smad3 to the 
corresponding promoters. JMJD3 targeting triggers H3K27 demethylation and 
subsequent transcriptional initiation, while Smad3 is displaced and no longer required for 
stable JMJD3 binding. Moreover, the active recruitment of JMJD3 to the non-H3K27-
methylated Ctgf promoter and the low decrease of H3K27me3 at methylated promoters, 
suggests that JMJD3 may have an additional role in transcriptional activation, beyond its 
HDM activity on H3K27me3.  
 
TGFβ-induced neurogenesis in the spinal cord requires JMJD3 
The findings described above support the idea that Smad3, together with JMJD3, 
regulates genes important for neural development (Figure 2C and Figure 3F). Hence, we 
tested whether JMJD3 cooperates with the TGFβ pathway in an in vivo model of neural 
development, the chick embryo neural tube. Structurally, 3 zones can be distinguished in 
a transversal section of neural tube; the ventricular zone (VZ) where proliferating 
progenitors reside, the transition zone (TZ) where neuroblasts exit the cell cycle to 
initiate differentiation, and the mantle zone (MZ) where final differentiated neurons 
reside (Figure 5B). We first examined the expression domains of Smad3 and JMJD3 in 
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developing spinal cord. In situ hybridizations (ISH) of transverse sections of Hamburger 
and Hamilton (HH) stage 24-26 embryos showed that both mRNA were expressed in 
similar domains: in the dorsal part of the VZ, and in the TZ (Figure 5A and 5B). In 
addition, Smad3 immunostaining experiments show a similar distribution of active 
(nuclear) Smad3 (Figure S6). The extended colocalization of Smad3 and JMJD3 along 
the dorso-ventral axis of the TZ in the neural tube (Figure 5A and 5B) and the previously 
reported function of Smad3 inducing neuronal differentiation in this model (Garcia-
Campmany and Marti, 2007) suggest that Smad3 and JMJD3 could functionally 
cooperate in developing spinal cord. 
To analyze the function of the proteins of interest, we electroporated the 
recombinant DNAs cloned in a bicistronic vector containing GFP sequence in the neural 
tube, thus the EP cells were GFP positive (GFP+).  It has been previously shown that 
overexpression of the pseudo-phosphorylated Smad3 (Smad3S/D) in the chick neural 
tube promotes neuronal differentiation [(Garcia-Campmany and Marti, 2007) and Figure 
5C-5J]. The neuronal differentiation phenotype can be monitored in three ways: (i) lateral 
distribution of GFP-positive cells; (ii) analysis of progenitor markers; and (iii) neuronal 
differentiation marker expression. Figures 5C and 5D show that Smad3S/D in ovo EP 
cells differentiate earlier and, as a consequence, are mainly in the MZ of the neural tube 
where fully differentiated neurons are found, in contrast to the even distribution observed 
for the empty vector EP cells (Figure 5C and 5D). In line with this, Smad3S/D EP cells 
are excluded from the progenitor zone stained with Sox2 marker (Figure 5E and 5F), and, 
on the other hand, express high levels of the neuronal differentiation markers HuC/D and 
Tuj1 (Figure 5G-4J). We then wondered if Smad3 mediated phenotype was related to 
JMJD3 overexpression, with this purpose we checked JMJD3 mRNA levels upon Smad3 
  17 
electroporation, but we did not observe any increase in the transcript of the demethylase 
(Figure S7). 
Next we sought to assess the role of endogenous JMJD3 on Smad3-induced 
neuronal differentiation. With this aim we first cloned an shRNA for chick JMJD3 in a 
bicistronic vector containing GFP sequence, which efficiently reduces JMJD3 levels 
(Figure 5K). Then, we electroporated in ovo Smad3S/D together with shJMJD3 and 
analyzed the previously described markers. First, we investigated the distribution of 
GFP+ cells; In this case, co-EP GFP+ cells failed to migrate to the MZ, in contrast to EP 
Smad3 S/D cells, indicating that the lack of JMJD3 counteracts Smad3 neurogenic 
induction (Figure 5C and 5D). Moreover Smad3S/D and shJMJD3 co-EP cells expressed 
higher levels of Sox2 proliferation marker than Smad3S/D EP cells (percentage of 
Sox2+/GFP+ cells: empty vector 55.43%, Smad3S/D 6.54%, Smad3S/D together with 
shRNA-JMJD3 56.26%) (Figure 5E and 5F). In addition, the total number of Sox2+ cells 
in the EP side was recovered, counteracting the global progenitors reduction promoted by 
Smad3 (Figure S8A). Furthermore, Smad3-shJMJD3 co-EP cells express less HuC/D and 
Tuj1 differentiation markers than Smad3S/D EP cells (percentage of HuCD+/GFP+ cells: 
empty vector 48.96%, Smad3S/D 84.22%, Smad3S/D together with shRNA-JMJD3 
41.24%; percentage of Tuj1+/GFP+ cells: empty vector 47.74%, Smad3S/D 85.23%, 
Smad3S/D together with shRNA-JMJD3 45.33%) (Figure 5G-5J and Figure S8C). And 
accordingly to the global changes observed in the progenitors population, the increase of 
differentiated cells (HuCD+ or Tuj1+) promoted by EP of Smad3S/D was impaired in 
Smad3- shJMJD3 co-EP neural tubes (Figure S8B). To further confirm the cooperation of 
JMJD3 with active Smad3 to induce neuronal differentiation we performed JMJD3 gain 
of function experiments. Results in Figure S9 strongly support our previous results by 
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showing that co EP of Smad3S/P and JMJD3 WT leads to premature and ectopic 
neuronal differentiation induction. 
 As the endogenous chick Smad3 is active (Figure S6) we tested the effect of loss 
of function of JMJD3 on endogenous neuronal differentiation. Electroporation of 
shJMJD3 alone had a blocking effect on endogenous neuronal differentiation (Figure 
S10A- S10D), that equally affects dorsal and ventral terminally differentiated neurons 
(Figure S10E- S10G). These results strongly indicate that JMJD3 is required for Smad3 
to induce neuron generation in chick embryo spinal cord. 
  Next, we wondered about the correlation between the observed phenotypes and 
the H3K27me3 status of the EP cells. With this aim, we checked the H3K27me3 levels of 
shJMJD3 and JMJD3 WT EP cells. Results in Figure S11 indicate that even though we 
could not detect a global increase in the H3K27me3 levels in JMJD3 depleted cells 
(probably due to technical limitations), we observed a decrease in H3K27me3 signal 
upon EP of JMJD3 WT. Moreover, this global demethylation promoted by JMJD3 WT 
electroporation correlates with the dramatic neuronal differentiation observed when 
Smad3 is co-electroporated with JMJD3 WT (Figure S9). Overall, these results point to 
an important function of JMJD3 regulating H3K27me3 levels in the neural tube. 
 
Smad3-JMJD3 cooperation requires JMJD3 HDM activity   
 Based on our previous data, we assessed whether the requirement of JMJD3 for 
TGFβ-induced neurogenesis in developing spinal cord depends on the HDM activity 
mediated by the JumonjiC domain of JMJD3. To this end, we used a JMJD3 mutant 
lacking HDM activity that acts as a dominant negative form of JMJD3 (JMJD3 DN) 
[(Akizu et al., 2010), Figure S11)]. Figures 5C-5J show that co-electroporation of JMJD3 
DN together with Smad3S/D, counteracts Smad3-induced neuronal differentiation, 
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similar to the effect observed upon EP of Smad3S/D and shJMJD3. Again, 
electroporation of JMJD3 DN alone blocks endogenous neuronal differentiation (Figure 
S10A-S10G). These findings demonstrate that the demethylase activity of JMJD3 is 
essential for Smad3-induced neurogenesis.  
 
NeuroD1 is regulated by Smad3 and JMJD3 HDM activity  
 Our data using NSCs indicates that Smad3 and JMJD3 cooperate to co-regulate 
genes important for neural development, among them class II bHLH genes essential for 
proper neurogenesis (Ngn2 and Id3). bHLH activators show temporal expression 
sequence during central nervous system development; based on that they can be further 
divided into neural determination factors such as the proneural genes, Mash1, Ngn1 and 
Ngn2, which are expressed in proliferating neural progenitors at the initiation of neuronal 
differentiation, and neural differentiation factors, such as NeuroD1 that is mainly 
expressed in young post-mitotic neurons undergoing neuronal differentiation (Figure 6A 
and Figure S12A). In order to investigate the implication of JMJD3 regulating the 
expression of late bHLH genes we use the developing chicken neural tube where TGFβ 
signaling induces terminal neural differentiation and patterning specification (Garcia-
Campmany and Marti, 2007). We first confirm that the proneural gene Ngn2 is also a 
TGFβ target that requires JMJD3 activity to full induction in chick neural tube. To do 
that, Smad3S/D together with shJMJD3 or JMJD3 DN vector were in ovo electroporated, 
the neural tubes were dissected out 24h later and GFP+ cells sorted by FACS were 
processed for RNA extraction and analyzed by qPCR (Figure 6B). Results in Figure 
S12B shows that in chicken neural tube TGFβ also induces Ngn2 gene expression, 
moreover this induction was partially blocked by overexpression of JMJD3 DN or 
shJMJD3 together with the TGFβ effector. Once confirmed that the proneural gene Ngn2 
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is also a TGFβ and JMJD3 target in chicken neural tube, we tested whether Smad3 and 
JMJD3 promoted neurogenesis by co-regulating late bHLH genes, such as NeuroD1. 
With this aim, 48h EP GFP+ cells were sorted for RNA extraction or ChIP assays (Figure 
6B). Figure 6C shows that Smad3S/D electroporation induces NeuroD1 expression. This 
induction was severely counteracted by overexpression of JMJD3 DN or shJMJD3 
together with the TGFβ effector (Figure 6C). According with NeuroD1 mRNA 
expression levels, Co-EP of JMJD3 DN blocked Smad3 induced H3K27 demethylation 
on the NeuroD1 promoter (Figure 6D). To check whether this regulation occurs through a 
direct binding of Smad3 and JMJD3 to NeuroD1 promoter we electroporated Flag-Smad3 
or Myc-JMJD3 and performed ChIP assays in EP cells using Flag or Myc antibodies.  
Results in Figure 6E and 6F show that Flag-Smad3 binds NeuroD1 promoter, but this is 
not the case for Myc-JMJD3.  As our previous results in NSCs indicated that JMJD3 
requires Smad3 to target promoters (Figure 4G) we electroporated Flag-Smad3 together 
with Myc-JMJD3 and performed a new Myc-JMJD3 ChIP assay. Results in Figure 6F 
show that Myc-JMJD3 is recruited to NeuroD1 promoter in cells co-EP with the TGFβ 
effector, confirming our previous results that JMJD3 targeting requires Smad3 (Figure 
4G).  
 Overall, our findings highlight an essential role of JMJD3 activity for Smad3-
dependent neural vertebrate development through co-regulation of early (Ngn2) and late 
(NeuroD1) master genes for neuronal differentiation.   
 
DISCUSSION  
Our results demonstrate by genome-wide analysis and experiments in vertebrate 
embryos that TGFβ response is largely dependent on the Smad3 co-regulator JMJD3.    
Although a large number of Smad cofactors have been previously described, how 
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they provide specificity and plasticity to TGFβ response is still unknown. Recent studies 
have shown that master transcription factors, such as Oct4 in ESCs, Myod1 in myotubes 
and PU.1 in pro-B cells select cell-type-specific response to TGFβ signaling (Mullen et 
al., 2011). Our studies expand this knowledge showing that not a transcription factor, but 
an epigenetic regulator determines the TGFβ outcome during development. Our results 
demonstrate that JMJD3 recruitment to Smad3-targeted promoters is essential to trigger 
the transcriptional activation of TGFβ-responsive genes that are key for development. As 
we have shown, JMJD3 depletion compromises the transcriptional regulation of 
developmental genes. Moreover, in the chick neural tube JMJD3 is essential for Smad3-
induced neuronal differentiation.  
 By establishing a molecular link between JMJD3 and TGFβ signaling, our study 
provides new insight into how a developmental signal is integrated into chromatin to 
provide the transcriptional plasticity required during development. In addition, our data 
propose a dynamic H3K27me3 targets behaviour, modulated by signal-dependent 
targeting, that recruits JMJD3 by DNA sequence-specific transcription factor Smad3 to 
neuronal genes. The knowledge about how histone demethylases are recruited to the 
promoter regions is very limited. It has been shown that T-box transcription factors 
recruit H3K27me3 demethylases to chromatin (Miller et al., 2008; Miller and Weinmann, 
2009). Similarly, p53 by interacting with JMJD3 cooperates to control neurogenesis (Sola 
et al., 2011). Moreover, recent data have revealed that Smad2/3 and Smad1 (Akizu et al., 
2010; Dahle et al., 2010; Kim et al., 2011) by interacting with JMJD3 recruit it to some 
loci. Our data extend these findings showing that (i) JMJD3 specifically interacts with 
Smad3 and (ii) this association occurs in almost 7000 promoters in NSCs, moreover (iii) 
we demonstrate that JMJD3 is essential for Smad3 to activate transcription of key neural 
genes. Finally, our finding reveals that (iiii) TGFβ-dependent neuron generation in chick 
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embryo spinal cord requires JMJD3 activity (Figure 6G). 
 The contribution of H3K27me3 demethylation to JMJD3-mediated transcriptional 
activation is an intriguing question. Our results indicate that H3K27me3 levels decrease 3 
h after TGFβ treatment in the methylated promoters (Figure 4C). However, the active 
recruitment of JMJD3 to the non-H3K27-methylated like Ctgf promoter and the low 
decrease of H3K27me3 at methylated promoters, suggests that in addition to H3K27me3 
demethylation other JMJD3-dependent functions might be involved in TGFβ-responsive 
promoter activation as it has been previously proposed (De Santa et al., 2009; Miller et 
al., 2010). Finally, our data with JMJD3 DN clearly demonstrate that HDM activity is 
required to facilitate TGFβ-induced neuronal differentiation as well as to demethylate and 
activate the key NeuroD1 promoter. These results open the possibility that other essential 
factors different than histone H3 might be targeted by JMJD3 HDM activity upon TGFβ 
signaling activation. This hypothesis would explain the dependency of HDM activity for 
the JMJD3 function and the lack of correlation with H3K27me3 levels at some analyzed 
promoters. 
In addition to TGFβ pathway, other developmental signaling pathways might also 
utilize JMJD3 to increase the rate of transcription of responsive genes. In agreement with 
this idea, our laboratory has recently shown that JMJD3 regulates the BMP pathway by 
interacting with Smad1 in developing chick spinal cord (Akizu et al., 2010). These data 
open the possibility that effectors from different signaling pathways may compete with 
one another for binding and recruitment of JMJD3 to a different set of genes in a 
particular spatial and temporal order. In line with this, JMJD3 function would depend on 
the combination of active signaling pathways in each developmental stage. 
 In summary, this study identifies a new TGFβ signaling-dependent JMJD3 
regulatory function demonstrating a role for this demethylase in neural vertebrate 
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development. Due to the broad range of TGFβ functions in other processes such as 
cancer, it would now be interesting to investigate the role of TGFβ-dependent JMJD3 
transcriptional regulation in other cellular contexts.  
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FIGURE LEGENDS  
Figure 1. Endogenous Smad3 and JMJD3 interact in NSCs 
(A) Size-exclusion chromatography of NSC lysate showing co-elution of Smad3P and 
JMJD3 and the presence of Smad3 in the lower weight fractions.  
(B) Co-IP of mouse NSCs lysate using anti-Smad3P antibody or unrelated IgGs in the 
presence or absence of TGFβ for 30 min.  
(C) Upper panel shows schematic representation of GST-Smad3 fragments: full length 
(FL), MH1 (1-155 aa), MH2 (199-425 aa) and linker domains that also contains MH2 
(146-425 aa). Pull-down assay using GST-Smad3 fusion proteins and 293t cell extracts 
overexpressing Myc-JMJD3. Ponceau staining of GST-Smad3 proteins (lower panel).  
(D) Immunoblot from control knockdown (C KD) and JMJD3 knockdown (JMJD3 KD) 
cell extracts using the indicated antibodies.  
(E) Immunoblot showing Nestin expression prior to and after TGFβ treatment for the 
indicated times in C KD and JMJD3 KD cells. Nestin levels (relative to Actin) were 
quantified by using the Image J software (graph on the right).  
Input (In) corresponds to 1% of the protein present in the whole cell extract.  
Figure 2. TGFβ and JMJD3 regulate common target genes  
(A) Schematic representation of microarray analysis design. 
(B) Diagrams depict the number of TGFβ-responsive genes that need JMJD3 to be 
efficiently up (on the left) or down regulated (on the right).  
(C) GO analysis of the TGFβ-responsive genes dependent on JMJD3. 
Figure 3. Smad3 and JMJD3 co-localize on gene promoters 
(A) ChIP-Seq experimental procedure. 
(B) Distribution of the distance of Smad3 (blue) and JMJD3 (red) peaks from the TSS. 
(C) Venn diagram showing promoters (-1000 to TSS) co-bound by Smad3 and JMJD3. 
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(D) Representation based on BED files obtained for Smad3 and JMJD3 (see legend) 
binding sites on Ngn2 and Slc16a6 promoters. 
(E) Venn diagrams showing genes co-bound by Smad3 and JMJD3 (±1000pb from 
TSS) that are transcriptionally up regulated (on the left) or down regulated by TGFβ 
and JMJD3 (on the right). 
(F) GO analysis of genes co-bound by Smad3 and JMJD3 that are transcriptionally 
regulated by TGFβ and JMJD3 (407 targets; 215 up- plus 192 down-regulated). 
Figure 4. Smad3 recruits JMJD3 to promoters in response to TGFβ 
(A-D) ChIPs [of Smad3 (A), JMJD3 (B) and H3K27me3 (C)] and mRNA levels (D) 
analyzed by qPCR were performed in NSCs left untreated (0 h) or treated with TGFβ (30 
min, 3 h or 6 h). Graphs on the right represent the mean levels at the analyzed promoters. 
(E) Immunoblot from C KD and Smad3 KD cell extracts using the indicated antibodies. 
(F-G) ChIPs of Smad3 (F) and JMJD3 (G) analyzed by qPCR at the indicated promoters 
were performed prior to and after TGFβ treatment (30 min) in C KD, JMJD3 KD and 
Smad3 KD NSC lines (see coloured squares in legend).  
ChIP results are presented as fold enrichment over a region negative for Smad3 and 
JMJD binding (G6pd2 gene, see Table S2). Hbb is an additional negative control 
represented in the graph. Three biological replicates were used in each ChIP experiment.  
Figure 5. Smad3 and JMJD3 cooperate to induce neuronal differentiation in chick 
spinal cord  
(A) Smad3 and JMJD3 mRNA ISHs in HH25-26 embryo spinal cord. 
(B) Schematic representation of Smad3 and JMJD3 expression domains shown in (A).  
(C, E, G and I) HH12 embryos were electroporated in ovo with the DNAs (cloned into a 
bicistronic vector containing GFP) indicated in the vertical boxes and processed (48 h 
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PE) for the indicated immunostaining. The right side corresponds to the electroporated 
side (GFP positive). 
(D) Quantification of the lateral distribution of GFP+ cells from the lumen to the mantle 
zone of the neural tube (see Methods). 
(F, H, J) Graphs showing the percentage of electroporated cells (GFP+) positive for 
Sox2, HuCD and Tuj1 respectively. Data are the mean of n=30 sections (from 4-6 
embryos).  
 (K) JMJD3 mRNA levels were determined by qPCR from sorted EP neural tube cells 
(GFP+) with the empty vector (E. vector) or shRNA of JMJD3 containing vector 
(shJMJD3) for 48 h. 
Figure 6. Neuro D1 is a  target  of Smad3 and JMJD3 in the neural tube 
(A) Schematic representation of bHLH genes expression along neurogenesis. 
(B) Schematic representation of chick embryo RNA extraction and ChIP procedures. 
 (C) NeuroD1 mRNA levels from EP neural tube cells (GFP+) with the indicated DNAs 
were determined by qPCR.  
(D-F) ChIPs analyzed by qPCR from EP neural tube cells (GFP+) with DNAs indicated 
on the   x-axis of the graphs using H3K27me3 (C) , Flag (D)  and Myc (E) antibodies at 
the NeuroD1 promoter. Results are represented as fold enrichment over negative binding 
regions for Smad3 and JMJD3. Tll promoter was used as negative control for Smad3 and 
JMJD3 binding and Hes5 promoter as negative control for H3K27me3. Three biological 
replicates were used in each experiment.  
 (G) Schematic diagram summarizing our results. In the non EP side of the neural tube 
Smad3 drives neuronal differentiation activating the expression of neuronal genes in the 
TZ (such as NeuroD1) together with JMJD3. In the side EP with loss of function (LOF) 
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of JMJD3, Smad3 is not able to efficiently activate proneural genes leading a reduction in 
the number of differentiated neurons (see HuC/D marker in red).     






